Literature DB >> 9745091

Solitary fibrous tumor of the liver with CD 34 positivity and hypoglycemia.

A Guglielmi1, M Frameglia, P Iuzzolino, G Martignoni, G De Manzoni, E Laterza, G F Veraldi, R Girlanda.   

Abstract

We report a new case of solitary fibrous tumor (SFT) of the liver, an extremely rare neoplasm. Including the present case no more than ten cases are reported in the English-language literature. To date there is no definite proof of the origin of this tumor. Both mesothelial and fibroblas-tic genesis has been postulated. The monoclonal antibody CD 34 has recently been used for the characterization of SFT. SFT would appear to be histogenetically related to a CD 34 - positive fibroblastic stem cell. A 61-year-old woman was admitted to our department with epigastric and right hypochondriac pain, weight loss, and hypoglycemia. Ultrasonography and computed tomography demonstrated a large heterogeneous mass in the right hepatic lobe. A right hepatectomy was performed. The tumor weighed 2850 g and microscopic section revealed a peculiar random pattern, the so-called patternless pattern of spindle tumor cells separated by abundant thick collagen bands. The tumor presented a number of highly cellular areas composed of plump spindle cell with hyperchromatic nuclei and rare mitotic figures. Ninety percent of the neoplastic cells displayed strong immunoreactivity for CD 34/My 10. The postoperative course was uneventful and the patient is alive and well without recurrence 6 years after surgery.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9745091     DOI: 10.1007/s005340050036

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Surg        ISSN: 0944-1166


  9 in total

1.  Solitary fibrous tumour of the liver with IGF-II-related hypoglycaemia. A case report.

Authors:  F Famà; Yves Le Bouc; G Barrande; A Villeneuve; M G Berry; R R Pidoto; O Saint Marc
Journal:  Langenbecks Arch Surg       Date:  2008-04-17       Impact factor: 3.445

2.  Solitary fibrous tumor of the liver: a case report.

Authors:  Ke Sun; Jian-Ju Lu; Xiao-Dong Teng; Li-Xiong Ying; Jian-Feng Wei
Journal:  World J Surg Oncol       Date:  2011-03-29       Impact factor: 2.754

Review 3.  Solitary fibrous tumor of the liver expressing CD34 and vimentin: a case report.

Authors:  Dimitris-P Korkolis; Katerina Apostolaki; Chrysanthi Aggeli; George Plataniotis; Emmanuel Gontikakis; Dimitra Volanaki; Maria Sebastiadou; Dimitris Dimitroulopoulos; Dimitris Xinopoulos; George-N Zografos; Perikles-P Vassilopoulos
Journal:  World J Gastroenterol       Date:  2008-10-28       Impact factor: 5.742

4.  Characterisation of a novel cell line (CSQT-2) with high metastatic activity derived from portal vein tumour thrombus of hepatocellular carcinoma.

Authors:  T Wang; H S Hu; Y X Feng; J Shi; N Li; W X Guo; J Xue; D Xie; S R Liu; M C Wu; S Q Cheng
Journal:  Br J Cancer       Date:  2010-05-11       Impact factor: 7.640

Review 5.  Solitary fibrous tumour of the liver: case report and review of the literature.

Authors:  Hannes Neeff; R Obermaier; K Technau-Ihling; M Werner; C Kurtz; A Imdahl; U T Hopt
Journal:  Langenbecks Arch Surg       Date:  2004-06-19       Impact factor: 3.445

Review 6.  Solitary Fibrous Tumor of the Liver: a Review of the Current Knowledge and Report of a New Case.

Authors:  Marcelo A Beltrán
Journal:  J Gastrointest Cancer       Date:  2015-12

Review 7.  Skull base metastases from a malignant solitary fibrous tumor of the liver. A case report and literature review.

Authors:  Lu Peng; Yang Liu; Yongbiao Ai; Zhisu Liu; Yueming He; Quanyan Liu
Journal:  Diagn Pathol       Date:  2011-12-22       Impact factor: 2.644

Review 8.  Solitary fibrous tumour of the liver-report on metastasis and local recurrence of a malignant case and review of literature.

Authors:  Nelson Chen; Kellee Slater
Journal:  World J Surg Oncol       Date:  2017-01-18       Impact factor: 2.754

Review 9.  Primary solitary fibrous tumors of liver: a case report and literature review.

Authors:  Qiang Liu; Jing Liu; Wenyou Chen; Shunbao Mao; Yihe Guo
Journal:  Diagn Pathol       Date:  2013-12-02       Impact factor: 2.644

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.